IPOWala.in adds IPO, and Buybacks & Authorizations coverage that ORTEX skips.
VOL. XCIV, NO. 247
★ A CURATED DIRECTORY OF FINANCIAL TOOLS ★
PRICE: 5 CENTS
Wednesday, December 17, 2025
Tool Comparison
IPOWala.in vs ORTEX comparison
Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.
Quick takeaways
ORTEX includes Short Interest, Insider Data, Quant, Index Rebalancing, Money Flow, Options & Derivatives, Options, Analyst Recommendations, Analyst Price Targets, News, Data APIs, US Government Trades, Screeners, and Blogs categories that IPOWala.in omits.
ORTEX offers mobile access, which IPOWala.in skips.
In depth comparison
IPOWala.in
ipowala.in
India-focused IPO information portal (NSE/BSE context) with a live IPO Grey Market Premium (GMP) page and other IPO tracking pages (subscription status, allotment links, listing-performance tables, and buyback lists). GMP content is stated as informational only; the site states it does not trade, deal, or support grey-market / “subject-to” transactions, and recommends consulting a SEBI-registered advisor.
Platforms
Pricing
Quick highlights
- Live IPO Grey Market Premium (GMP) tables for Mainboard and SME IPOs, showing IPO name, GMP (₹), issue price (₹), expected gain %, and an “Updated as of” timestamp.
- Upcoming IPO table with open/close dates and issue price (calendar-style listing).
- IPO subscription status tables (live + previous) with category-wise oversubscription multiples (QIB/NII/Retail/Total), referencing NSE/BSE bid data.
- IPO allotment status table with allotment dates and outbound “View Status” links to registrar allotment-status pages (e.g., KFintech, MUFG Intime, Bigshare), plus how-to steps.
- IPO listing performance / “IPO Performance Analysis” tables showing listing date, issue price, listing price, and gain/loss %, with separate sections for mainboard and SME.
Community votes (overall)
ORTEX
public.ortex.com
Analytics platform focused on short interest and securities lending, with additional coverage of options flow, insider trades, analyst views, and index rebalances. Offers a free tier with limited features, plus paid plans (Basic $39/mo, Advanced $129/mo). Options data is sourced from OPRA and requires agreeing to OPRA terms. API access is available with key-based authentication, and an Excel Add-in (beta) supports short interest data.
Categories
Platforms
Pricing
Quick highlights
- Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers.
- Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates.
- Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms.
- Alpha trading signals across themes like Short Squeeze, EPS, RSI, MACD, and Company Events, each with back-tested stats and intraday updates.
- Configurable stock screener including short-interest columns; results can be exported.
Community votes (overall)
Where they differ
IPOWala.in
Distinct strengths include:
- Live IPO Grey Market Premium (GMP) tables for Mainboard and SME IPOs, showing IPO name, GMP (₹), issue price (₹), expected gain %, and an “Updated as of” timestamp.
- Upcoming IPO table with open/close dates and issue price (calendar-style listing).
- IPO subscription status tables (live + previous) with category-wise oversubscription multiples (QIB/NII/Retail/Total), referencing NSE/BSE bid data.
- IPO allotment status table with allotment dates and outbound “View Status” links to registrar allotment-status pages (e.g., KFintech, MUFG Intime, Bigshare), plus how-to steps.
ORTEX
Distinct strengths include:
- Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers.
- Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates.
- Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms.
- Alpha trading signals across themes like Short Squeeze, EPS, RSI, MACD, and Company Events, each with back-tested stats and intraday updates.
Feature-by-feature breakdown
| Attribute | IPOWala.in | ORTEX |
|---|---|---|
Categories Which research workflows each platform targets | Shared: Calendar, Data Visualizations Unique: IPO, Buybacks & Authorizations | Shared: Calendar, Data Visualizations Unique: Short Interest, Insider Data, Quant, Index Rebalancing, Money Flow, Options & Derivatives, Options, Analyst Recommendations, Analyst Price Targets, News, Data APIs, US Government Trades, Screeners, Blogs |
Asset types Supported asset classes and universes | Stocks | Stocks, ETFs, Options |
Experience levels Who each product is built for | Beginner, Intermediate | Beginner, Intermediate, Advanced |
Platforms Where you can access the product | Web | Web, Mobile, API |
Pricing High-level pricing models | Free | Free, Subscription |
Key features Core capabilities called out by each vendor | Unique
| Unique
|
Tested Verified by hands-on testing inside Find My Moat | Not yet | Yes |
Editor pick Featured inside curated shortlists | Standard listing | Standard listing |
Frequently Asked Questions
Which workflows do IPOWala.in and ORTEX both support?
Both platforms cover Calendar, and Data Visualizations workflows, so you can research those use cases in either tool before digging into the feature differences below.
Do IPOWala.in and ORTEX require subscriptions?
Both IPOWala.in and ORTEX keep freemium access with optional paid upgrades, so you can trial each platform before committing.
Which tool has mobile access?
ORTEX ships a dedicated mobile experience, while IPOWala.in focuses on web or desktop access.
What unique strengths set the two platforms apart?
IPOWala.in differentiates itself with Live IPO Grey Market Premium (GMP) tables for Mainboard and SME IPOs, showing IPO name, GMP (₹), issue price (₹), expected gain %, and an “Updated as of” timestamp., Upcoming IPO table with open/close dates and issue price (calendar-style listing)., and IPO subscription status tables (live + previous) with category-wise oversubscription multiples (QIB/NII/Retail/Total), referencing NSE/BSE bid data., whereas ORTEX stands out for Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers., Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates., and Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms..
Keep exploring
Keep exploring
Stay on top of related tools
Browse the categories and profiles that overlap most with this comparison to round out your shortlist.
Related categories
Follow the same themes these tools compete in.
Recommended tools
These profiles share overlapping coverage with both sides of this matchup.
- GuruFocusEditor's pickHands-on review
Overlap: Screeners, Data Visualizations, and US Government Trades.
ScreenersData VisualizationsUS Government Trades - Fiscal.aiEditor's pickHands-on review
Overlap: Screeners, Data Visualizations, and Insider Data.
ScreenersData VisualizationsInsider Data - MarketWatchHands-on review
Overlap: News, Calendar, and Screeners.
NewsCalendarScreeners - Nasdaq.comHands-on review
Overlap: Screeners, News, and Calendar.
ScreenersNewsCalendar - TrendlyneHands-on review
Overlap: Screeners, Analyst Price Targets, and Analyst Recommendations.
ScreenersAnalyst Price TargetsAnalyst Recommendations - Börsdata
Overlap: Screeners, Data Visualizations, and Index Rebalancing.
ScreenersData VisualizationsIndex Rebalancing
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.